BofA Sees Positive Outlook for Novartis and GSK With Upcoming Milestones
The pharma sector is walking into 2025 with fresh momentum, and two big names are getting extra attention. Bank of America (BofA) recently shared a positive outlook on Novartis and GSK, pointing to several major milestones expected in the coming months. These updates matter because both companies are entering a crucial phase in their research…